Isocitrate dehydrogenase 1 mutant glioblastomas demonstrate a decreased rate of pseudoprogression: a multi-institutional experience.
Mohammadi H, Shiue K, Grass GD, Verma V, Engellandt K, Daubner D, Schackert G, Gondim MJ, Gondim D, Vortmeyer AO, Kamer AP, Jin W, Robinson TJ, Watson G, Yu HM, Lautenschlaeger T.
Mohammadi H, et al. Among authors: verma v.
Neurooncol Pract. 2020 Mar;7(2):185-195. doi: 10.1093/nop/npz050. Epub 2019 Oct 10.
Neurooncol Pract. 2020.
PMID: 32626587
Free PMC article.